Hormone Shows Potential as Treatment for Alzheimer's and Stroke

Hormone Shows Potential as Treatment for Alzheimer's and Stroke

Researchers at Saint Louis University have identified a novel way of delivering a potential treatment for Alzheimer's and stroke into the brain. The brain is protected by the blood-brain barrier, a gate-keeping system of cells that lets in nutrients and keeps out foreign substances.

The blood-brain barrier passes no judgment on which foreign substances are trying to get into the brain to treat Alzheimer's and which are trying to do harm, so it blocks them without discrimination.

The therapy is a hormone produced by the body that is a general neuro-protectant, and is known as PACAP27 (pituitary adenylate cyclase-activating polypeptide). PACAP27 is a general protector of the brain against many types of insult and injury.

They used mouse models of Alzheimer's disease and stroke to test what would happen if PACAP27 could get into the brain. The scientists isolated the particular gatekeeper than evicts PACAP27. Then they designed an antisense, a specific molecule that turned off the gatekeeper.

Turning off the gatekeeper that kept PACAP27 out of the brain allowed enough of the hormone that already is in the body to get inside the brain, where it effectively treated strokes. The mice that had a version of Alzheimer's needed both an extra dose of PACAP27 and the antisense that turned off the gatekeeper to improve learning.

The symptoms of the disease were reversed and the mice that had Alzheimer’s became smarter and in the stroke model, the amount of damage caused by the blockage of blood to the brain was reduced.
References:
1. William A. Banks, et al. Hormone shows promise in reversing Alzheimer’s disease and stroke. Saint Louis University. November 2008.
2. Image by Patrick J. Lynch, medical illustrator; C. Carl Jaffe, MD, cardiologist.

Researchers Establish Link Between Obesity and Alzheimer's Disease Risk

A study has found that obese people had 8 percent less brain tissue than people with normal weight, while overweight people had 4 percent less tissue, putting them at greater risk of

Polyphenol and PUFA Rich Diet Could Delay Onset of Alzheimer's Disease

Researchers have confirmed that a diet rich in polyphenols and polyunsaturated fatty acids (PUFAs) helps boost the production of the brain's stem cells (neurogenesis) and strengthens their

Researchers Develop Risk Index Tool to Help Predict Alzheimer's

Researchers have developed a new risk index tool that can help predict whether people age 65 and older have a high risk of developing Alzheimer's. Differential characteristics are pointed

Chemicals Found in Food Derived From Plants Offer Hope for Alzheimer's

According to a dementia expert, a group of chemicals found in many fruits and vegetables, as well as tea, cocoa and red wine could protect the brain from Alzheimer’s disease. Dark

Phase 2 Gene Therapy Trial to Stop Progression of Alzheimer's Disease

A phase II, double-blind, placebo-controlled gene therapy trial for the treatment of patients with dementia due to Alzheimer's disease is underway. The technique uses CERE-110 as the gene